secwatch.observer — SEC 8-K summary
======================================

Issuer:     TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
CIK:        0000818686
Form:       8-K
Filed at:   2026-09-16T20:25:25+00:00
Accession:  0001193125-26-393116
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teva issues €1.5B and $3.2B senior notes; proceeds to redeem existing notes
---------------------------------------------------------------------------

- Issued €1.0B 4.250% notes due 2033 and €0.5B 4.625% notes due 2036.
- Issued $1.0B 5.500% notes due 2034, $1.0B 5.750% notes due 2037, and $1.2B 5.250% notes due 2032.
- Proceeds redeem all 6.750% 2028, 7.875% 2029, 7.375% 2029, and 8.125% 2031 notes; up to $450M of 2027 notes and €1.15B of 2030 notes.
- Remaining proceeds for general corporate purposes; notes guaranteed by Teva on senior unsecured basis.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818686/000119312526393116/0001193125-26-393116-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818686/000119312526393116/d155511d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-393116

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer